Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

Stanford University316 enrolled

Overview

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Study Type

OBSERVATIONAL

Enrollment

316

Conditions

Coronavirus

Interventions

There is no interventionOTHER

There is no intervention

Eligibility

Sex: ALLMin age: 2 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults (18 years and older) and children with confirmed COVID-19 (RT-PCR diagnosis). * Adults (18 years and older) and children without COVID-19 for controls (who test negative for COVID-19 but may have viral symptoms) Exclusion Criteria: * Patients with special risks attendant to venipuncture will be excluded.

Locations (2)

Stanford Health Care - ValleyCare

Pleasanton, California, United States

Stanford University, Hospital, and Clinics

Stanford, California, United States

Outcomes

Primary Outcomes

Testing Immunity to SARS-CoV-2 over time

Time frame: 1 year

Secondary Outcomes

Testing the virus over time

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.